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ABSTRACT 
A hemoperfusion system has been developed which 
makes use of activated carbon encapsulated with 
cellulose acetate. Studies have revealed that there 
are no stagnant flow regions in  the column, there i? 
minimal particle release and the coating is 30A 
thick. The relationships between pore size, pore 
volume and surface area have been examined. 
Twenty-five patients in grade IV coma have been 
treated with the column for treatment of drug over- 
dose or agricultural chemical poisoning; the clinical 
course of one meprobamate-poisoned patient is de- 
scribed in detail. 
activated carbon, cellulose acetate coating, hemo- 
perfusion) poisoning 
INTRODUCTION 
Its enormous internal surface area (- 1000 m2/gm) 
makes activated carbon (AC) a n  effective adsorbent 
for many polar and non-polar molecules from 
aqueous solutions and blood. In 1964 Yatzidis' de- 
scribed the effectiveness of a n  AC hemoperfusion 
column for the removal of metabolites and drugs 
from blood. Ever since, many investigators have 
applied AC in hemoperfusion systems to adsorb 
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toxic substances. Encapsulation of the AC granules 
with polymeric membranes provides improved 
blood compatibility and minimizes the release of 
embolizing micro particle^.^-^ 
This is a report on a novel hemoperfusion 
column containing 250 gm of Norit RBX 1 micro- 
encapsulated with cellulose acetate. This column 
has been developed a t  the Twente University of 
Technology with the  a s s i s t ance  of Organon 
Teknika (Oss, The Netherlands). The thickness of 
the coating is approximately 30 A, which is ex- 
tremely thin compared to other coated AC hemoper- 
fusion systems used clinically at present (Table). 
This ultrathin coating affects the rate of removal 
only very slightly as compared to uncoated AC. The 
new hemoperfusion column, which will be marketed 
by Organon Teknika under the name "Hemopur 
260)', has been applied in  the treatment of acute 
poisoning by drugs and agricultural chemicals. The 
results in the treatment of a patient poisoned with 
meprobamate will be described. The pat ient  
recovered within a few days without side effects. 
DESCRIPTION O F  THE COLUMN 
Figure 1 shows the column diagrammatically. It 
contains approximately 250 gm of coated AC gran- 
ules and is primed with carbon dioxide (COz). Prior 
to clinical.use the column is perfused with 2 L of 
saline. The COz charge provides a wetted carbon 
surface,  allowing optimal participation of the 
internal surface area in the adsorption process and 
preventing channeling of the blood flow. 
The flow pattern in the column has been studied 
a t  a water flow rate of 200 ml/min and temperature 
of 25°C using a stimulus-response technique.6 Stag- 
nant flow regions did not occur within the cylindri- 
cal column. The in uitro microparticle release has 
been determined a t  a water flow rate of 200 ml/min. 
The particle concentrations in the outflow of the 
column, collected over a six-hour perfusion period, 
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outlet were well below the British7 and U.S.* standards for 
infusion fluids. 
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FIG. 1. Diagram of the hemoperfusion column. 
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FIG. 2. Volume V of pores with radius (R) < 75,000 A v s .  pore 
radius R for: a .  uncoated Norit RBX 1; b. Norit coated with cellu- 
lose acetate (0.7'71, by weight). 
THICKNESS OF THE COATING 
The thickness of the cellulose acetate (CA) coating 
has been determined using high pressure porosi- 
metry (porosimeter: Carlo Erba model 70, Italy).g 
The cumulative pore volume distributions of un- 
coated Norit RBX 1 have been compared (Fig. 2). 
From Figure 2 it can be seen that below 2000 A, the 
internal surface area of the pores is not coated. The 
CA membrane bridges these small pores. The sur- 
face area of tpe internally coated pores (radius 
above 2000 A)  can  be calculated f rom t h e  
cumulative pore volume distribution assuming that 
the AC exhibits cylindrical pores. From the density 
of the cellulose acetate membrane and the percen- 
tage by weight of CA (0.7%) the membrane thick- 
ness can be computed. 
Columns containing Norit RBX 1 granules 
coated with 0.32% CA by weight have been used in 
the treatment of acute poisoning by drugs and agri- 
cultural chemicals. CA membrane thickness is 
approximately 30 A. 
The Table shows the membrane thickness of the 
coated AC hemoperfusion system to be small com- 
pared to other types used clinically. The membrane 
thickness is an important parameter with respect to 
the mass transfer rate of a substance through a 
membrane. From the membrane thickness point of 
view the rate of removal of toxic products from the 
blood to the carbon surface for the CA-encapsulated 
Norit RBX 1 will be superior to those of other hemo- 
perfusion systems mentioned in the Table. 
CLINICAL RESULTS 
Thus far, 25 patients in grade IV coma due to a n  
overdose of various drugs and agricultural chemi- 
cals have been treated with the described hemoper- 
fusion column. Hydrophobic as well as hydrophilic 
poisons have been removed effectively. The therapy 
used to remove the toxins includes: a) stomach wash- 
out; b) administration of magnesium sulfate and 
powdered AC via the stomach into the intestines; 
c) forced diuresis if possible; and d) hemoperfusion. 
The data of a patient with a n  overdose of meproba- 
mate will be described, being representative of the 
authors' experience. 
The perfusion circuit is shown in Figure 3. The 
blood pump produces an  antigravity blood flow 
through the column of 300 ml/min. Figure 4 shows 
the removal of meprobamate during the hemoper- 
fusion period. The effect of forced diuresis on the 
meprobamate level will be minimal in this four-hour 
period."J During the four hours of hemoperfusion, 
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FIG. 3. Hemoperfusion circuit. 
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FIG. 4. The removal of meprobamate from a patient by the 
Organon Teknika Detoxicator a t  a blood flow rate of 300 ml/min. 
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FIG. 5. Blood cell counts and blood flow resistance vs. time dur- 
ing hemoperfusion treatment of the meprobamate-poisoned 
patient. 
the serum level of meprobamate fell from 80 pg/ml 
to 25 pg/ml with improvement in clinical responses. 
Crome et all1 reported the treatment of a severe 
meprobamate poisoning with a coated-AC column 
of Smi th  a n d  Nephew (Haemocol,  Smi th  a n d  
Nephew, Ltd., London, England). Under similar 
conditions (blood flow rate of 300 ml/min; four 
hours  of perfusion) the  p lasma meprobamate  
concentration decreased from 97 pg/ml to 62 pg/ml. 
The blood cell counts a n d  the blood flow resis- 
tance of the column have been plotted as a function 
of the perfusion time as shown in Figure 5. The 
platelet level reduction of approximately 16% did 
not lead to thrombocytopenia. The constancy of the 
blood flow resistance during hemoperfusion shows 
the complete absence of flow-inhibiting factors. 
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TABLE 
MEMBRANE THICKNESS FOR VARIOUS COATED- 
CHARCOAL HEMOPERFUSION SYSTEMS 
System Activated carbon Polymeric coating Membrane thickness 
(m) 
Chang: ACAC Fisher albumin-cellulose 0.05 
(Canada) nitrate (= 500 A) 
Gambro: Norit RBX 1 cellulose 
Adsorba 300 C 
(Sweden) 
Smith & Nephew: Sutcliffe acrylic 
Haemocol Speakman hydrogel 
(England) 
Organon Teknika Norit RBX 1 cellulose 
“Hemopur 260” acetate 
(The Netherlands) 
3 - 5  
5 
0.0030 
(= 30 A) 
3. FENNIMORE, J. WATSON, P. A., MUNRO, G. D., KOLTHAMMER, 
J. C. The design and evaluation of a convenient carbon 
haemoperfusion system. Proc Eur SOC Artif Organs, 1:90, 
1974. 
CONCLUSIONS 
On the basis of the clinical results obtained in the 
treatment of the 25 poisoned patients the following 
conclusions can be made: 1) using the Organon 
Teknika “Hemopur 260” column, patients in grade 
IV coma due to a n  overdose of drugs or poisons 
come rapidly to consciousness, and the recovery 
period of the patients in the Intensive Care Unit is 
shortened considerably. 2) During and after the 
treatment no harmful side effects are noted. 
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